Precipio (PRPO) Net Income towards Common Stockholders (2010 - 2025)
Precipio's (PRPO) quarterly Net Income towards Common Stockholders came in at $526000.0 in Q4 2025, up 244.11% YoY from $152858.3 in Q4 2024, and up 765.82% on a QoQ basis from -$79000.0 in Q3 2025.
Precipio (PRPO) Net Income towards Common Stockholders (2010 - 2025) Analysis & Trends
Precipio (PRPO) has 16 years of Net Income towards Common Stockholders data on file, last reported at $526000.0 in Q4 2025.
- Quarterly Net Income towards Common Stockholders rose 244.11% year-over-year to $526000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$363000.0 (up 91.54% YoY) and the FY2025 annual result came in at -$347000.0, up 91.81% from the prior year.
- Net Income towards Common Stockholders advanced to $526000.0 in Q4 2025, from -$79000.0 in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $925000.0 in Q4 2023 to a low of -$4.6 million in Q1 2022.
- A 5-year average of -$1.6 million and a median of -$1.7 million in 2021 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders tumbled 216.12% — and 2025, when it surged 244.11%.
- Tracing PRPO's Net Income towards Common Stockholders over 5 years: stood at -$2.2 million in 2021, then decreased by 3.85% to -$2.3 million in 2022, then soared by 140.39% to $925000.0 in 2023, then tumbled by 139.46% to -$365000.0 in 2024, then surged by 244.11% to $526000.0 in 2025.
- The last three Net Income towards Common Stockholders figures came in at $526000.0 (Q4 2025), -$79000.0 (Q3 2025), and $74000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 338.41 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 324.00 Mn |
| 10 | Precipio | 36.29 Mn | 33.64 Mn | 3.13 Mn | 526,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 526,000.00 |
| Sep 30, 2025 | -79,000.00 |
| Jun 30, 2025 | 74,000.00 |
| Mar 31, 2025 | -884,000.00 |
| Dec 31, 2024 | -365,000.00 |
| Sep 30, 2024 | -626,000.00 |
| Jun 30, 2024 | -1.22 Mn |
| Mar 31, 2024 | -2.08 Mn |
| Dec 31, 2023 | 925,000.00 |
| Sep 30, 2023 | -1.46 Mn |
| Jun 30, 2023 | -2.29 Mn |
| Mar 31, 2023 | -3.03 Mn |
| Dec 31, 2022 | -2.29 Mn |
| Sep 30, 2022 | -3.18 Mn |
| Jun 30, 2022 | -2.14 Mn |
| Mar 31, 2022 | -4.59 Mn |
| Dec 31, 2021 | -2.21 Mn |
| Sep 30, 2021 | -1.86 Mn |
| Jun 30, 2021 | -3.01 Mn |
| Mar 31, 2021 | -1.45 Mn |